The FDA has approved a surgical ablation system (Synergy, AtriCure) for the treatment of atrial fibrillation (AF). It is indicated for use in patients with persistent and long-standing persistent AF during open-heart concomitant CABG and/or valve replacement or repair procedures.
Source: AtriCure.
